OPC-64005

N/A

Report date: 2025/01/14 11:38:37
NME

Base Information

Drug NameOPC-64005
Drug Alias NameOPC-64005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitorsNorepinephrine reuptake inhibitorsSerotonin reuptake inhibitors
TargetsDopamine transporterNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active IndicationsDepressive Disorder, Major
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A